VivoSeq
Other

Upper Gastrointestinal Endoscopy

3

Pipeline Programs↗

0

Active Trials↗

1

Companies Involved↗

Upper Gastrointestinal Endoscopy is an early-stage landscape with 3 programs across 1 company. The most active players are Nihon Pharmaceutical Co., Ltd. 3 therapies are approved.

Intelligence

Pipeline Metrics

Competitive Density

21/100

Pipeline Velocity

0/100

Mech. Concentration

100/100

Completion Rate

83/100

Attrition Rate

17/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

N

Nihon Pharmaceutical Co., Ltd

0 programs

Preclinical

Pipeline

Programs by Phase

Preclinical
No programs
Phase 1
No programs
Phase 2
No programs
Phase 3
No programs
Approved3

Dexmedetomidine and Propofol

Anesthesia Research Group UA

Midazolam and Propofol

Dan Liu

Ketamine

Aultman Health Foundation

Analysis

Trial Status

12

clinical trials

Completed10 · 83%
Terminated2 · 17%

Clinical Trials

Trial Activity

12 trials

Pharynx Analgesia Before Upper Gastrointestinal Endoscopy
Completed·—·N/A·NCT06220175·37 enrolled
Clinical Trial With Bupivacaine Lozenges as Local Anaesthesia Under Upper Gastrointestinal Endoscopy
Completed·—·Phase 2·NCT01832675·100 enrolled
Evaluation of Topical Lidocaine Spray as Adjuvant to Upper Gastrointestinal Endoscopy in Children
Completed·HHospital Infantil Cândido Fontoura·Phase 3·NCT00521703·78 enrolled
Effect of Palatable Lidocaine Gel on Gag Reflex for Patients Undergoing Upper Gastrointestinal Endoscopy
Completed·ZZagazig University·N/A·NCT04213833·120 enrolled
Phase III Open-labeled Study of NPO-11 in Patients Undergoing Therapeutic Upper Gastrointestinal Endoscopy
Completed·NNihon Pharmaceutical Co., Ltd·Phase 3·NCT01411189·33 enrolled
Spasmolytic in Upper Gastrointestinal Endoscopy
Completed·KKonya Meram State Hospital·Phase 4·NCT02576340·400 enrolled
Phase III Study of NPO-11 in Patients Undergoing Therapeutic Upper Gastrointestinal Endoscopy
Completed·NNihon Pharmaceutical Co., Ltd·Phase 3·NCT01411176·85 enrolled
Premedication With Alprazolam and Midazolam for Upper Gastrointestinal Endoscopy
Completed·IIsfahan University of Medical Sciences·Phase 2/3·NCT03130842·136 enrolled
Oropharyngeoesophageal Topical Anesthesia Prototype Device Versus Intravenous (Propofol -Ketamine Sedation) for Upper Gastrointestinal Endoscopy
Completed·ZZagazig University·Preclinical·NCT07563062·60 enrolled
Efficacy of Propofol Combination With Either Ketamine, Dexmedetomidine or Midazolam for Sedation During Upper Gastrointestinal Endoscopic Procedures: A Prospective, Randomized, Comparative Study
Completed·AAin Shams University·Approved·NCT07190612·75 enrolled
Preoperative Viscous Lidocaine for Upper Gastrointestinal Endoscopy
Terminated·—·Phase 4·NCT04725695·119 enrolled
Ketamine and Propofol Combination Versus Propofol for Upper Gastrointestinal Endoscopy
Terminated·IIcahn School of Medicine at Mount Sinai·Phase 4·NCT02643979·22 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)